Juvenile and adult-onset ALS/MND among Africans: incidence, phenotype, survival: A review

References

• Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68: 1002–7.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, . Incidence of amyotrophic lateral sclerosis in Europe. Journal of neurology, neurosurgery, and psychiatry. 2010;81:385–90.
   PubMed Web of Science ®Google Scholar
• Ben Hamida M, Hentati F. [Charcot's disease and juvenile amyotrophic lateral sclerosis]. Rev Neurol (Paris). 1984; 140:202–6.
   PubMedGoogle Scholar
• Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Descriptive epidemiology of motor neuron disease in Benghazi, Libya. Neuroepidemiology. 1986;5:47–54.
   PubMedGoogle Scholar
• Bougteba A, Basir A, Birouk N, Belaidi H, Kably B, Ouazzani R. Sclérose latérale amyotrophique au Maroc. Etude de 276 cas. Journ e de Neurologie de Langue Fran aise; 2005; Rev Neurol (Paris). 2005;161:S97.
   Google Scholar
• Harries JR. Amyotrophic lateral sclerosis in Africans. East Afr Med J. 1955;32:333–5.
   PubMedGoogle Scholar
• Adam AM. Unusual form of motor neuron disease in Kenya. East Afr Med J. 1992;69:55–7.
   PubMedGoogle Scholar
• Abdulla MN, Sokrab TE, el Tahir A, Siddig HE, Ali ME. Motor neurone disease in the tropics: findings from Sudan. East Afr Med J. 1997;74:46–8.
   PubMedGoogle Scholar
• Tekle-Haimanot R, Abebe M, Gebre-Mariam A, Forsgren L, Heijbel J, Holmgren G, . Community-based study of neurological disorders in rural central Ethiopia. Neuroepidemiology. 1990;9:263–77.
   PubMed Web of Science ®Google Scholar
• Jacquin-Cotton L, Dumas M, Girard PL. Les paraplégies au Sénégal. Bull Soc Méd Afr Noire Lgue fr. 1970;15:206–20.
   PubMedGoogle Scholar
• Collomb H, Virieu R, Dumas M, Lemercier G. Maladie de Charcot et syndromes de sclérose latérale amyotrophique au Sénégal. Etude clinique de 27 observations. Bull Soc Méd Afr Noire Lgue fr. 1968;13:785–804.
   Google Scholar
• Ndiaye IP, Ndiaye M, Gueye M, Ndiaye MB. Les maladies dégénératives de la moelle. Congress of the Pan African Association of Neurological Sciences; 1986; Abidjan (Côte d'Ivoire).
   Google Scholar
• Sene Diouf F, Ndiaye M, Toure K, Ndao AK, Thiam A, Diop AG, . Aspects cliniques et épidémiologiques de la sclérose latérale amyotrophique à la clinique neurologique de Dakar. Dakar Médical. 2004;49:167–71.
   PubMedGoogle Scholar
• Osuntokun BO, Adeuja AO, Bademosi O. The prognosis of motor neuron disease in Nigerian africans. A prospective study of 92 patients. Brain. 1974;97:385–94.
   PubMedGoogle Scholar
• Imam I, Ogunniyi V. What is happening to motor neuron disease in Nigeria? Annals of African Medicine. 2004;3:1–3.
   Google Scholar
• Piquemal M, Beugre K, Boa Yapo F, Giordano C. Etude clinique de 30 observations de syndrome de sclérose latérale amyotrophique observés en Côte d'Ivoire. Afri J Neuro Sci. 1982;1:31–40.
   Google Scholar
• Kengne AP, Dzudie A, Dongmo L. Epidemiological features of degenerative brain diseases as they occurred in Yaounde referral hospitals over a 9-year period. Neuroepidemiology. 2006;27:208–11.
   PubMedGoogle Scholar
• Le Bigot P. Profil épidémiologique des affections neurologiques au Gabon. In: AUPELF-UREF, editor. Neurologie Tropicale. Paris: John Libbey Eurotext; 1993. p. 17–21.
   Google Scholar
• Wall DW, Gelfand M. Motor neuron disease in Rhodesian Africans. Brain. 1972;95:517–20.
   PubMedGoogle Scholar
• Mielke J, Adamolekun B. Motor neuron disease in Zimbabwe. Congress of the Pan African Association of Neurological Sciences; May 19th -23rd 1996; Durban (South Africa).
   Google Scholar
• Cosnett JE, Bill PL, Bhigjee AI. Motor neuron disease in blacks. Epidemiological observations in Natal. S Afr Med J. 1989;76:155–7.
   PubMedGoogle Scholar
• Philippe Y, Ayats H, Debroise B. Pseudo-sclérose latérale amyotrophique par cyphoscoliose dorsale. Bull Soc Méd Afr Noire Lgue fr. 1961;4:260–4.
   Google Scholar
• Reynaud R, Massat R, Le Bot F. Pseudo-sclérose latérale amyotrophique, pachyméningite hypertrophique et cervicarthrose. Bull Soc Méd Afr Noire Lgue fr. 1965;10:32–5.
   PubMedGoogle Scholar
• Rafik R, Bourazza A, Mounach J, Zerhouni A, Hssaini Y, Boutaleb N, ., editors. Syndrome de sclérose latérale amyotrophique et syphilis : trois cas. Journée de Neurologie de Langue Française; 2006; Toulouse: Rev Neurol (Paris). 2006;162:2S98.
   Google Scholar
• Ouhabi H, Bourazza A, Rouimi A, Boutaleb N, Mosseddaq R. Association sclérose latérale amyotrophique et sclérodermie : étude de 2 cas. Rev Neurol (Paris). 1997;153:790–1.
   PubMedGoogle Scholar
• McCluskey K, McCluskey L. Racial disparity in mortality from ALS/MND in US African Americans. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:73–8.
   Google Scholar
• McGuire V, Longstreth WT, Jr., Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 1996;47:571–3.
   PubMed Web of Science ®Google Scholar
• Leone M, Chandra V, Schoenberg BS. Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology. 1987;37:1339–43.
   PubMed Web of Science ®Google Scholar
• Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998. Neurology. 2005;64: 1215–21.
   PubMed Web of Science ®Google Scholar
• Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol. 1991;48:589–93.
   PubMed Web of Science ®Google Scholar
• Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci. 1995;132:207–15.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT, Jr., McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Kahana E, Alter M, Feldman S. Amyotrophic lateral sclerosis: a population study. J Neurol. 1976;212:205–13.
   PubMedGoogle Scholar
• Drory VE, Artmonov I. Earlier onset and shorter survival of amyotrophic lateral sclerosis in Jewish patients of North African origin. A clue to modifying genetic factors? J Neurol Sci. 2007;258:39–43.
   PubMed Web of Science ®Google Scholar
• Elian M, Dean G. Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean, and east and west Africa. J Neurol Neurosurg Psychiatry. 1993;56:454–7.
   PubMed Web of Science ®Google Scholar
• Tomik B, Nicotra A, Ellis CM, Murphy C, Rabe-Hesketh S, Parton M, . Phenotypic differences between African and white patients with motor neuron disease: a case-control study. J Neurol Neurosurg Psychiatry. 2000;69: 251–3.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci. 1994;124:96–107.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011;36:29–38.
   PubMed Web of Science ®Google Scholar
• Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, . Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003;61:742–9.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, . Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain : a journal of neurology. [Research Support, Non-U.S. Gov't]. 1995;118:707–19.
   Google Scholar
• Li TM, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. Journal of neurology, neurosurgery, and psychiatry. 1988;51:778–84.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, . Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10:310–23.
   PubMed Web of Science ®Google Scholar
• Norris F, Shepherd R, Denys E, U K, Mukai E, Elias L, Holden D . Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993;118: 48–55.
   PubMed Web of Science ®Google Scholar
• Gouveia LO, de Carvalho M. Young-onset sporadic amyotrophic lateral sclerosis: a distinct nosological entity? Amyotroph Lateral Scler. 2007;8:323–7.
   PubMed Web of Science ®Google Scholar